Hochschulschrift
Isovalerianazidämie : Klinik, Pathobiochemie und Therapie am Beispiel von 28 Patienten
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
Erscheinungsjahr an der Haupttitelstelle: 2004
Freiburg (Breisgau), Univ., Diss., 2005
- Schlagwort
-
Proteinstoffwechselstörung ; Stoffwechselstörung ; Aminosäurenstoffwechselstörung ; Enzymopathie ; Leucin ; Isovaleryl-CoA-Dehydrogenase
- Urheber
- URN
-
urn:nbn:de:bsz:25-opus-17909
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
The phenotypic and genetic spectrum of glycogen storage disease type VI
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
The phenotypic and genetic spectrum of glycogen storage disease type VI
Organoazidopathien im Blickpunkt des Neugeborenen-Screenings - Wandel des klinischen Phänotyps und kritische Aspekte des Screenings
Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey